Background To date, the pathophysiology underlying symptoms in renal patients is still unclear.
INTRODUCTION
Patients undergoing dialysis treatment experience a plethora of disease-and treatment-related symptoms. High symptom burden is associated with reduced health-related quality of life (HRQOL), 1 and increased morbidity and mortality in dialysis patients. 2 Symptoms can be hard to treat and the pathophysiology underlying these symptoms is still unclear. 3 Weak associations were often found between symptoms and clinical variables. 3, 4 Symptom clustering is a relatively new topic currently explored in symptom management research. Symptom clusters refer to concurrent symptoms related to each other. 5 These concurrent symptoms, in theory, can have a synergistic relationship. Clinical relevance of symptom cluster research could provide insights into common underlying mechanism(s) associated with multiple symptoms.
Research on symptom clustering in dialysis patients is scarce. To our knowledge, only two studies have identified symptom clusters in dialysis patients. 6, 7 Both these studies had small samples limited to haemodialysis (HD) patients and did not investigate the correlations of the symptom clusters with clinical variables.
Our objectives are to identify symptom clusters in incident HD and peritoneal dialysis (PD) patients, and examine associations between symptom clusters, clinical variables and HRQOL.
Clinical implications of our study include identifying symptom clusters in dialysis patients that could provide a theoretical framework to study the possible determinants underlying symptom experience, and thereby assist in symptom management.
METHODS PATIENT SAMPLE
Between January 1997 and January 2007, incident dialysis patients from 38 dialysis centres throughout the Netherlands were recruited with informed consent to participate in The Netherlands Co-operative Study on the Adequacy of Dialysis (NECOSAD-2), 8 a prospective observational study investigating the adequacy of care for patients on dialysis treatment.
Eligibility included being over 18 years of age, with no previous history of renal replacement therapy, being alive at 3 months (baseline), and having a symptom score assessed at baseline. 
STATISTICAL ANALYSES
Differences between continuous variables were assessed using the Mann-Whitney test, whilst categorical outcomes were tested using the Chi-square test. Twelve symptoms from the KDQOL were entered into a principal component analysis (PCA) using varimax rotation. PCA is a suitable technique to identify underlying dimensions as it reduces multiple variables into smaller number of variables or components that describe the data most efficiently. 18 Varimax rotation was used as it maximises the variance of the loadings within each component whilst assuming independence of the component structure. 18 Components with Eigenvalues >1 were retained for further analysis. The Eigenvalue is equivalent to the amount of variance explained by a component. Items in each resultant component were summed to form the subscale score.
Reliability (Cronbach's alpha) for the items within each component was also examined. To assess the association of comorbidity with the symptom clusters, comorbid conditions of angina pectoris, myocardial infarct, cardiac failure, coronary artery disease, cardiovascular accident, and peripheral vascular disease were combined to indicate the presence of cardiovascular diseases (CVD). Significance levels were determined at p≤ 0.05. SPSS version 12.0 was used for the statistical analyses.
RESULTS
Of the 1,712 eligible patients alive at three months after start of dialysis, 159 (9.3%) patients had missing baseline symptom score. Patients with a missing symptom score had higher levels of
Chapter 3 56 CRP, poorer nutritional status, and lower functional ability compared with those with a symptom score. Table 1 outlines the baseline characteristics of HD and PD patients. More males were treated with PD. Compared with HD patients, PD patients were younger, were more likely to be married, and had a higher level of education. In terms of clinical parameters, PD patients more often had glomerulonephritis as the primary cause of kidney disease, had a higher rGFR, had a higher level of haemoglobin, had a higher level of calcium, were better nourished, had less comorbid illnesses, had lower prevalence of erythropoietin use, had lower CRP, and a lower phosphorus level. Furthermore, PD patients scored higher on all SF-36 quality of life dimensions, and had higher level of functioning when compared with HD patients.
The most prevalent symptoms include sore muscles, itch, dry skin, and cramps (as reported by patients of being 'some bother' or more), while patients had least complaints of problems with access site/shunt and chest pains ( Figure 1 ). No association was found between symptoms and seasonal variation. Our sample experienced on average 2.8 (± 2.4) concurrent symptoms which they reported of being at least of 'moderate bother' (a score of 3 or higher on the symptom scale). Nearly 49% of the sample reported of being bothered with 3 or more symptoms which were of moderate bother or higher.
Exploratory principal component analysis extracted three clusters with Eigenvalues greater than 1 from 11 symptoms ( Table 2 ). The symptom of problem with access site/shunt did not load significantly onto any of the 3 symptom clusters. Total amount of variance explained by these three statistically derived clusters was 49%. Cronbach's alpha for the clusters ranged from 0.58 to 0.70.
Cluster 1 included symptoms such as shortness of breath, feeling faint/dizzy, poor appetite, feeling 'squeezed out', and feeling nauseous. As these symptoms are often indicative of uraemia, we labelled this cluster as 'general symptoms of the uremic syndrome'. The second cluster consisted of symptoms such as sore muscles, chest pain, and numbness in the hands/feet. These symptoms could reflect disturbances in patients' neuromuscular functions, and was therefore labelled 'neuromuscular problems'. The symptoms of itch and dry skin make up Cluster 3, which could reflect an underlying dimension of 'skin problems'. Values in bold indicate the factor loading of the symptom in each symptom cluster A 3-cluster solution for HD and PD patients separately gave no materially different results, and had similar cluster loadings as reported in Table 2 . Table 3 outlines the correlations of the 3 clusters with HRQOL, demographic, and clinical variables, separate for HD and PD patients. In both groups, all three clusters were significantly correlated with each other (0.350 to 0.502) and negatively correlated with each of the SF-36 subscales, ranging from -0.142 to -0.593. Similarly, the Karnofsky Index scores were negatively correlated with all 3 clusters in both the HD and PD samples. On the other hand, correlations with clinical parameters were less strong. Among HD patients, only serum albumin and haemoglobin were significantly correlated with all three symptom clusters. CVD was correlated with Cluster 1, while diabetes mellitus was negatively correlated with both Cluster 1 and Cluster 2 in the HD sample. In the PD group, Kt/Vurea was significantly correlated with all three symptom clusters, whilst Cluster 3 was significantly correlated with rGFR, phosphorus, and calcium. Both CVD and diabetes mellitus were significantly correlated with Cluster 2 only in the PD sample. Self-management refers to the health promotion and patient education programmes developed to encourage behaviour change and assist in adjustment to a chronic illness. 24 A small experimental study designed to reshape the self-representation of HD patients' coping skills on disease adjustment reported that the self-representation condition was more effective in improving adjustment, and alleviating depression and physical symptoms compared to two other treatment conditions, problem disclosure and control. 25 Comparing the symptom clusters identified in our study with those reported in other studies is difficult as the symptoms and the number of symptoms assessed in the different studies are varied. 6, 26 Nevertheless, some similarities in symptom loadings between our study and others were identified. For example, Cluster 2 ('neuromuscular problems') in our study shared some similarity with the 'mobility index' of Curtin et al 6 , which comprised of numbness in extremities, muscle soreness, muscle weakness, and bone/joint pain. Chiou 26 reported a 'disturbance in muscular function' cluster comprising of seven symptoms. Three of these symptoms (feeling dizzy/faint, shortness of breath, and poor appetite) were similarly loaded onto Cluster 1 ('general symptoms of uraemic syndrome') in our study. We interpreted these symptoms as reflecting an underlying uraemic syndrome rather than as disturbances in muscular function as suggested by
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The subjectivity in interpretation of symptom clusters is a possible limitation of our study. The clinical descriptions we have provided are subjective and debatable. Although principal component analysis is useful in data reduction and identifying possible underlying dimensions, nevertheless the subjective inclusion and interpretation of variables within each cluster/component could mean that our cluster solution might not have provided an adequate explanation for the data.
Secondly, we assessed the severity of 12 symptoms with the symptom problem list of the KDQOL-SF. This list with its predetermined symptoms has no free fields for patients to describe other possible symptoms. As such, our assessment might not encompass the whole symptom experience of dialysis patients.
Data on patients' illness perceptions, affect status, and strategies for self-management were not collected in our study. Future research could explore in greater detail the symptomatology experienced by dialysis patients by gathering information on, for instance, illness perceptions, self-efficacy, and self-management strategies. Such information can be incorporated into psycho-educational programmes to promote cognitive change so as to improve patients' selfefficacy and, thereby, self-management skills. 23 In conclusion, our study shows that dialysis patients experience concurrent symptoms, from which distinct clusters could be derived. These symptom clusters are all negatively associated with health-related quality of life dimensions, but have weak correlations with clinical variables.
To reduce patients' symptom burden, patients' cognitions and beliefs should be routinely assessed to ensure their self-management strategies can be appropriately supported.
